| ACN | Acetonitrile |
| AST | Astrocytoma |
| CSF | Cerebrospinal fluid |
| DIA | Data independent acquisition |
| DE | Differential expression/differentially expressed |
| EV | Extracellular vesicle |
| FA | Formic acid |
| GBM | Glioblastoma |
| GIV | Grade IV |
| GII-III | Grade II–III |
| HC | Healthy control |
| HILIC | Hydrophilic liquid chromatography |
| HPLC | High performance liquid chromatography |
| ID | Identification |
| IDA | Information dependent acquisition |
| IDH | Isocitrate dehydrogenase |
| iRT | Indexed retention time |
| LC- | Liquid chromatography tandem mass spectrometry |
| MEN | Meningioma |
| MRI | Magnetic resonance imaging |
| MS | Mass spectrometry |
| Mut | Mutation |
| NA | Not applicable |
| NTA | Nanoparticle tracking analysis |
| PBS | Phosphate buffered saline |
| PCA | Principal component analysis |
| RANO | Response Assessment in Neuro-Oncology |
| RT | Room temperature |
| SEC | Size exclusion chromatography |
| SWATH | Sequential window acquisition of all theoretic fragment ion spectra |
| TCEP | Tris(2-carboxyl) phosphine |
| TEAB | Tetraethylammonium bicarbonate |
| TEM | Transmission electron microscopy |
| TFA | Trifluoroacetic acid |
| TMZ | Temozolomide |
| TRiC | T-complex protein 1 ring complex |
| wt | Wild-type |